Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62P392L mutation to paget's disease

Noriyoshi Kurihara; Yuko Hiruma; Kei Yamana; Laëtitia Michou; Côme Rousseau; Jean Morissette; Deborah L. Galson; Jumpei Teramachi; Hua Zhou; David W. Dempster; Jolene J. Windle; Jacques P. Brown; G. David Roodman

doi:10.1016/j.cmet.2010.12.002

Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62^P392L mutation to paget's disease

Noriyoshi Kurihara, Yuko Hiruma, Kei Yamana, Laëtitia Michou, Côme Rousseau, Jean Morissette, Deborah L. Galson, Jumpei Teramachi, Hua Zhou, David W. Dempster, Jolene J. Windle, Jacques P. Brown, G. David Roodman

研究成果 › 査読

99 被引用数 (Scopus)

抄録

Paget's disease (PD) is characterized by abnormal osteoclasts (OCL) that secrete high IL-6 levels and induce exuberant bone formation. Because measles virus nucleocapsid gene (MVNP) and the p62^P392L mutation are implicated in PD, marrows from 12 PD patients harboring p62^P392L and eight normals were tested for MVNP expression and pagetic OCL formation. Eight out of twelve patients expressed MVNP and formed pagetic OCL in vitro, which were inhibited by antisense-MVNP. Four out of twelve patients lacked MVNP and formed normal OCL that were hyperresponsive to RANKL but unaffected by antisense-MVNP. Similarly, mice expressing only p62^P394L formed normal OCL, while mice expressing MVNP in OCL, with or without p62 ^P394L, developed pagetic OCL and expressed high IL-6 levels dependent on p38MAPK activation. IL-6 deficiency in MVNP mice abrogated pagetic OCL development in vitro. Mice coexpressing MVNP and p62^P394L developed dramatic Paget's-like bone lesions. These results suggest that p62 ^P394L and IL-6 induction by MVNP play key roles in PD.

本文言語	English
ページ（範囲）	23-34
ページ数	12
ジャーナル	Cell Metabolism
巻	13
号	1
DOI	https://doi.org/10.1016/j.cmet.2010.12.002
出版ステータス	Published - 1月 5 2011
外部発表	はい

ASJC Scopus subject areas

生理学
分子生物学
細胞生物学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1016/j.cmet.2010.12.002

他のファイルとリンク

引用スタイル

Kurihara, N., Hiruma, Y., Yamana, K., Michou, L., Rousseau, C., Morissette, J., Galson, D. L., Teramachi, J., Zhou, H., Dempster, D. W., Windle, J. J., Brown, J. P., & Roodman, G. D. (2011). Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62^P392L mutation to paget's disease. Cell Metabolism, 13(1), 23-34. https://doi.org/10.1016/j.cmet.2010.12.002

@article{cdde77f4a48448589c9d3ba6fdb564bb,

title = "Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62P392L mutation to paget's disease",

abstract = "Paget's disease (PD) is characterized by abnormal osteoclasts (OCL) that secrete high IL-6 levels and induce exuberant bone formation. Because measles virus nucleocapsid gene (MVNP) and the p62P392L mutation are implicated in PD, marrows from 12 PD patients harboring p62P392L and eight normals were tested for MVNP expression and pagetic OCL formation. Eight out of twelve patients expressed MVNP and formed pagetic OCL in vitro, which were inhibited by antisense-MVNP. Four out of twelve patients lacked MVNP and formed normal OCL that were hyperresponsive to RANKL but unaffected by antisense-MVNP. Similarly, mice expressing only p62P394L formed normal OCL, while mice expressing MVNP in OCL, with or without p62 P394L, developed pagetic OCL and expressed high IL-6 levels dependent on p38MAPK activation. IL-6 deficiency in MVNP mice abrogated pagetic OCL development in vitro. Mice coexpressing MVNP and p62P394L developed dramatic Paget's-like bone lesions. These results suggest that p62 P394L and IL-6 induction by MVNP play key roles in PD.",

author = "Noriyoshi Kurihara and Yuko Hiruma and Kei Yamana and La{\"e}titia Michou and C{\^o}me Rousseau and Jean Morissette and Galson, {Deborah L.} and Jumpei Teramachi and Hua Zhou and Dempster, {David W.} and Windle, {Jolene J.} and Brown, {Jacques P.} and Roodman, {G. David}",

note = "Funding Information: We thank Dr. Fujinami, Ph.D., University of Utah, for providing the AS-MVNP construct, and Donna Gaspich for preparing the manuscript. We also thank all patients who participated in this study, and Danielle Poulin for her outstanding support in clinical data collection and analysis. We thank Dr. Ramesh Ramakrishnan for assistance with statistical analyses. The research was funded by grant PO1-AR049363 (G.D.R.), R01 AR057308 (G.D.R.), R01 AR057310 (D.L.G.), and RO1 AR053537 (J.J.W.) from NIAMS, NIH/NCRR/CTSA Grant UL1 RR024153 and NIH/NCRR/GCRC Grant M01 RR000056, and by a grant from the Paget's Foundation. The materials are the result of work supported with resources and the use of facilities at the VA Pittsburgh Healthcare System, Research and Development, and the VCU Transgenic/Knockout Mouse Core, supported in part by the Massey Cancer Center Support Grant P30 CA016059. J.P.B. reports having served as a consultant to Amgen, Sanofi-Aventis, Warner-Chilcott, Merck, E. Lily, Novartis, Servier. G.D.R. reports having served as a consultant to Amgen, Novartis, Celgene, and Millennium and received grant support from Novartis as well. ",

year = "2011",

month = jan,

day = "5",

doi = "10.1016/j.cmet.2010.12.002",

language = "English",

volume = "13",

pages = "23--34",

journal = "Cell Metabolism",

issn = "1550-4131",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62P392L mutation to paget's disease

AU - Kurihara, Noriyoshi

AU - Hiruma, Yuko

AU - Yamana, Kei

AU - Michou, Laëtitia

AU - Rousseau, Côme

AU - Morissette, Jean

AU - Galson, Deborah L.

AU - Teramachi, Jumpei

AU - Zhou, Hua

AU - Dempster, David W.

AU - Windle, Jolene J.

AU - Brown, Jacques P.

AU - Roodman, G. David

N1 - Funding Information: We thank Dr. Fujinami, Ph.D., University of Utah, for providing the AS-MVNP construct, and Donna Gaspich for preparing the manuscript. We also thank all patients who participated in this study, and Danielle Poulin for her outstanding support in clinical data collection and analysis. We thank Dr. Ramesh Ramakrishnan for assistance with statistical analyses. The research was funded by grant PO1-AR049363 (G.D.R.), R01 AR057308 (G.D.R.), R01 AR057310 (D.L.G.), and RO1 AR053537 (J.J.W.) from NIAMS, NIH/NCRR/CTSA Grant UL1 RR024153 and NIH/NCRR/GCRC Grant M01 RR000056, and by a grant from the Paget's Foundation. The materials are the result of work supported with resources and the use of facilities at the VA Pittsburgh Healthcare System, Research and Development, and the VCU Transgenic/Knockout Mouse Core, supported in part by the Massey Cancer Center Support Grant P30 CA016059. J.P.B. reports having served as a consultant to Amgen, Sanofi-Aventis, Warner-Chilcott, Merck, E. Lily, Novartis, Servier. G.D.R. reports having served as a consultant to Amgen, Novartis, Celgene, and Millennium and received grant support from Novartis as well.

PY - 2011/1/5

Y1 - 2011/1/5

N2 - Paget's disease (PD) is characterized by abnormal osteoclasts (OCL) that secrete high IL-6 levels and induce exuberant bone formation. Because measles virus nucleocapsid gene (MVNP) and the p62P392L mutation are implicated in PD, marrows from 12 PD patients harboring p62P392L and eight normals were tested for MVNP expression and pagetic OCL formation. Eight out of twelve patients expressed MVNP and formed pagetic OCL in vitro, which were inhibited by antisense-MVNP. Four out of twelve patients lacked MVNP and formed normal OCL that were hyperresponsive to RANKL but unaffected by antisense-MVNP. Similarly, mice expressing only p62P394L formed normal OCL, while mice expressing MVNP in OCL, with or without p62 P394L, developed pagetic OCL and expressed high IL-6 levels dependent on p38MAPK activation. IL-6 deficiency in MVNP mice abrogated pagetic OCL development in vitro. Mice coexpressing MVNP and p62P394L developed dramatic Paget's-like bone lesions. These results suggest that p62 P394L and IL-6 induction by MVNP play key roles in PD.

AB - Paget's disease (PD) is characterized by abnormal osteoclasts (OCL) that secrete high IL-6 levels and induce exuberant bone formation. Because measles virus nucleocapsid gene (MVNP) and the p62P392L mutation are implicated in PD, marrows from 12 PD patients harboring p62P392L and eight normals were tested for MVNP expression and pagetic OCL formation. Eight out of twelve patients expressed MVNP and formed pagetic OCL in vitro, which were inhibited by antisense-MVNP. Four out of twelve patients lacked MVNP and formed normal OCL that were hyperresponsive to RANKL but unaffected by antisense-MVNP. Similarly, mice expressing only p62P394L formed normal OCL, while mice expressing MVNP in OCL, with or without p62 P394L, developed pagetic OCL and expressed high IL-6 levels dependent on p38MAPK activation. IL-6 deficiency in MVNP mice abrogated pagetic OCL development in vitro. Mice coexpressing MVNP and p62P394L developed dramatic Paget's-like bone lesions. These results suggest that p62 P394L and IL-6 induction by MVNP play key roles in PD.

UR - http://www.scopus.com/inward/record.url?scp=78650912040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650912040&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2010.12.002

DO - 10.1016/j.cmet.2010.12.002

M3 - Article

C2 - 21195346

AN - SCOPUS:78650912040

SN - 1550-4131

VL - 13

SP - 23

EP - 34

JO - Cell Metabolism

JF - Cell Metabolism

IS - 1

ER -